405 filings
Page 3 of 21
20-F/A
f5nc23q7aco79
4 Mar 19
Annual report (foreign) (amended)
7:05am
6-K
y8ldy
1 Mar 19
Primary Document
12:00am
424B3
537idldjqwz4r08
26 Feb 19
Prospectus supplement
5:25pm
424B3
lsjv2nijgr 9bzq
26 Feb 19
Prospectus supplement
5:21pm
6-K
p8agu2at
22 Feb 19
Primary Document
5:24pm
424B3
zvf6kk 68sq93ass6
20 Feb 19
Prospectus supplement
8:12am
424B3
5p78we7l8pk
20 Feb 19
Prospectus supplement
8:10am
6-K
0dj1a
20 Feb 19
Primary Document
8:06am
SC 13G/A
yqethmeqv
14 Feb 19
Intellipharmaceutics International Inc.
2:31pm
SC 13G/A
ea8 cht414w
14 Feb 19
Intellipharmaceutics International Inc.
1:44pm
424B3
f2eki1ek
4 Feb 19
Prospectus supplement
5:49pm
424B3
bnalhz3t5nkox05nod1g
4 Feb 19
Prospectus supplement
5:49pm
6-K
yl0o7hbketi
4 Feb 19
Intellipharmaceutics Appoints New Chief Financial Officer
5:10pm
SC 13G/A
5n3b7 4cv6tx3xcs0w
1 Feb 19
Intellipharmaceutics International Inc.
3:48pm
SC 13G/A
hldvt
29 Jan 19
Intellipharmaceutics International Inc.
3:40pm
SC 13G
7ur9x
29 Jan 19
Intellipharmaceutics International Inc.
3:30pm
424B3
d22gm8lyrg1fl0
28 Jan 19
Prospectus supplement
5:14pm
424B3
clkje
28 Jan 19
Prospectus supplement
5:11pm
6-K
piabsn322l1rr4
28 Jan 19
Intellipharmaceutics Receives Extension from Nasdaq Hearings Panel
5:06pm